TagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
AssigneeVanderbilt University
InventorsTimothy L. Cover, Martin J. Blaser, Harry Kleanthous, Murali K. R. Tummuru
Life of this patent
Estimating the term…
Loading patent…
AssigneeVanderbilt University
InventorsTimothy L. Cover, Martin J. Blaser, Harry Kleanthous, Murali K. R. Tummuru
Estimating the term…
The present invention provides an isolated nucleic acid encoding an approximately 120-128 kilodalton antigen of Helicobacter pylori, or an antigenic fragment thereof, wherein the antigen is associated with peptic ulceration. The present invention also provides methods of detecting the presence of a Helicobacter pylori strain possessing the 120-128 kilodalton antigen in a subject, comprising the steps of contacting an antibody-containing sample from the subject with a detectable amount of the tagA antigen or antigenic polypeptide of the present invention and detecting the binding of the antigen or fragment and the antibody. The detection of a strain expressing the TagA antigen is an indication of predisposition to peptic ulceration and gastric carcinoma. A mutant H. pylori not expressing a functional TagA antigen is also provided.
An isolated antigenic polypeptide, wherein the polypeptide consists of the amino acids encoded by nucleotides 1072 through 3648 contained in the nucleotide sequence defined in the Sequence Listing as SEQ ID NO:1.
An isolated antigenic polypeptide, wherein the polypeptide comprises the amino acids encoded by nucleotides 1072 through 3648 contained in the nucleotide sequence defined in the Sequence Listing as SEQ ID NO:1.
Dependencies are inferred from the claim text.